Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia

Trial Profile

Clinical Trial on Efficacy and Tolerability of Two Different Single Doses of Avanafil in Russia

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Mar 2016

At a glance

  • Drugs Avanafil (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Acronyms CEDAR
  • Sponsors Sanofi
  • Most Recent Events

    • 16 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 10 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 03 Aug 2015 Status changed from not yet recruiting to recruiting ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top